Overexpression of mutation of XPO1 has been implicated in various hematologic malignancies including chronic lymphocytic leukemia (CLL), primary mediastinal B-cell lymphoma (PMBL), classical Hodgkin lymphoma (cHL), and DLBCL [6,7,8]. The gene discussed is XPO1; the disease is classic Hodgkin lymphoma.